These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 21586604)
1. Identification of the factors that govern the ability of therapeutic antibodies to provide postchallenge protection against botulinum toxin: a model for assessing postchallenge efficacy of medical countermeasures against agents of bioterrorism and biological warfare. Al-Saleem FH; Nasser Z; Olson RM; Cao L; Simpson LL J Pharmacol Exp Ther; 2011 Aug; 338(2):503-17. PubMed ID: 21586604 [TBL] [Abstract][Full Text] [Related]
2. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library. Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M MAbs; 2014; 6(2):446-59. PubMed ID: 24492304 [TBL] [Abstract][Full Text] [Related]
3. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody. Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446 [TBL] [Abstract][Full Text] [Related]
4. Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: improved precision with in-bred mice. Rasetti-Escargueil C; Jones RG; Liu Y; Sesardic D Toxicon; 2009 Apr; 53(5):503-11. PubMed ID: 19673096 [TBL] [Abstract][Full Text] [Related]
5. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B. Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852 [TBL] [Abstract][Full Text] [Related]
7. Botulism: the many faces of botulinum toxin and its potential for bioterrorism. Villar RG; Elliott SP; Davenport KM Infect Dis Clin North Am; 2006 Jun; 20(2):313-27, ix. PubMed ID: 16762741 [No Abstract] [Full Text] [Related]
8. Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B. Held DM; Shurtleff AC; Fields S; Green C; Fong J; Jones RG; Sesardic D; Buelow R; Burke RL Clin Vaccine Immunol; 2010 Jun; 17(6):930-6. PubMed ID: 20410329 [TBL] [Abstract][Full Text] [Related]
9. [Intoxication of botulinum toxin]. Chudzicka A Pol Merkur Lekarski; 2015 Sep; 39(231):153-6. PubMed ID: 26449577 [TBL] [Abstract][Full Text] [Related]
11. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism. Simpson LL Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675 [TBL] [Abstract][Full Text] [Related]
12. Localization of the sites and characterization of the mechanisms by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin. Takahashi T; Joshi SG; Al-Saleem F; Ancharski D; Singh A; Nasser Z; Simpson LL Vaccine; 2009 Apr; 27(19):2616-24. PubMed ID: 19428868 [TBL] [Abstract][Full Text] [Related]
13. Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP). Torii Y; Takahashi M; Ishida S; Goto Y; Nakahira S; Harakawa T; Kaji R; Kozaki S; Ginnaga A Toxicon; 2010; 55(2-3):662-5. PubMed ID: 19781565 [TBL] [Abstract][Full Text] [Related]
14. Botulism and vaccines for its prevention. Smith LA Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283 [TBL] [Abstract][Full Text] [Related]
15. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain. Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503 [TBL] [Abstract][Full Text] [Related]